Vera Therapeutics, Inc. | Business Finance | Business Contracts

Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated February 1, 2023 (Filed With SEC on February 2, 2023)

First Amendment to Loan and Security Agreement, by and between the Registrant and Oxford Finance, LLC, dated November 4, 2022 (Filed With SEC on November 9, 2022)

Description of Common Stock of the Registrant (Filed With SEC on March 28, 2022)

Asset Purchase Agreement between the Registrant and Amplyx Pharmaceuticals, Inc. dated December 16, 2021 (Filed With SEC on February 7, 2022)

Loan and Security Agreement between the Registrant and Oxford Finance LLC, dated December 17, 2021 (Filed With SEC on February 7, 2022)

Form of Underwriting Agreement (Filed With SEC on February 7, 2022)

Vera Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 10, 2021)

Form of Class A Common Stock Certificate (Filed With SEC on May 10, 2021)

Form of Underwriting Agreement (Filed With SEC on May 10, 2021)

Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated October 29, 2020 (Filed With SEC on April 23, 2021)

Vera Therapeutics, Inc. (31) | Business Finance (10)